For Pharma
Data-Driven Decision-Making for
Adaptive Strategic Planning
Leverage Access to Real World Data for a Competitive Edge
Innovative Precision Health (IPH) is the first healthcare analytics company to provide multi-dimensional patient performance data and comparative efficacy metrics to maximize the entire pharmaceutical lifecycle, from development through market maturation.
![Leverage Access to Real World Data for a Competitive Edge](https://iph.email/wp-content/uploads/2020/07/Leverage-Access-to-Real-World-Data-for-a-Competitive-Edge-1.jpg)
Contextualize Proprietary, Objective Performance Data
IPH offers raw, de-identified, GxP-compliant data for pipeline research that integrates seamlessly with existing EHR systems and is collected from a proprietary network of specialty healthcare providers.
By creating digital assessments that integrate population health data, objective measurements, patient-reported outcomes, and clinical observations, IPH provides invaluable data for evaluating the efficacy of therapies at both the patient and population level.
Assess Product Development Value with Meaningful Outcome Measures
![Assess Product Development Value with Meaningful Outcome Measures](https://iph.email/wp-content/uploads/2020/07/Assess-Product-Development-Value-with-Meaningful-Outcome-Measures-1.jpg)
IPH affords access to meaningful, real-world data for comparative efficacy research and supports analytics for novel and existing therapies. Pharmaceutical companies leveraging access to a spectrum of objective patient performance data across products in the same disease state can help improve the design of clinical trials and gain a competitive edge in therapy development.
From identifying unmet needs to demonstrating the efficacy and real world value of assets under development, IPH delivers unmatched data-driven insights that are both personalized and scalable to address your pipeline targets.